Our advanced diagnostic offering uses a simple blood sample to assess key biomarkers linked to Alzheimer’s disease, helping to identify changes in the brain earlier than traditional methods. By combining multiple biological indicators with clinical expertise, it provides a clear, evidence-based assessment of Alzheimer’s risk. This enables faster, more informed decision-making and supports earlier access to the right care and next steps.

What’s included

• Advanced blood biomarker analysis associated with Alzheimer’s disease, including indicators linked to amyloid plaques and tau tangles
• Measurement of key protein ratios and markers associated with neurodegeneration and cognitive decline
• Integration of additional clinical factors (such as age and relevant health information) to support a more accurate assessment
• Personalised results presented as a clear, easy-to-understand risk or probability score
• Review and interpretation by an experienced clinician
• Dedicated health advisory support to guide you through your results and next steps
• Fast access to appointments and a streamlined, end-to-end clinical pathway in central London